Global Outreach Postings
Partners
Dr. Bernd Tersteegen, the founder of the Verband Deutsche Nierenzentren (DN) e.V., was dedicated to improving outpatient treatment modalities in end stage renal disease. Specifically, he focused on the further technical development of hemodialysis. The Bernd Tersteegen award was established following his death in 1995. The prize is awarded internationally for basic and particularly for clinical research related to chronic renal insufficiency and to advances in treatment of end stage renal disease.
The annual award of 8000 Euro is usually given to a single applicant but may be shared under certain circumstances. Applicants should be physicians, researchers or engineers who are involved in research in the area of renal failure and renal replacement therapy. Only research papers that have been published in 2011 or 2012 or have not yet been published are suitable for submission. Papers should be written in German or English. Review articles, dissertations, university habilitation works and manuscripts already entered in other competitions may not be submitted.
Groups of authors, who submit a work, must agree to the designation of a single speaker for the group. The written consent of all co-authors of a paper to the designation of the speaker must accompany the application. An abbreviated curriculum vitae and a list of publications to date should also be submitted.
Five copies of the work must be submitted by July 15, 2012 to the following address:
Verband Deutsche Nierenzentren (DN) e.V. President
Immermannstraße 65 A
40210 Düsseldorf
Germany
The members of the prize committee are chosen by the executive board of the DN. The president of the DN serves as chairman Bernd Tersteegen Award 2012 Committee. For further information CLICK HERE.
Introducing the Turkish Society of Nephrology
Written by Sally Horspool
The Turkish Society of Nephrology (TSN) was founded in Istanbul 41 years ago. Since then, it has played an important role in hosting events and meetings in the field of nephrology. Currently, TSN has 411 active members and Turkish membership at ISN has now reached 273.
Until May 31, 2012, TSN will organize continuous medical education courses on Hypertension and Nephrology for general practitioners. For further information, CLICK HERE. In the past, the different branches of the society have organized regular meetings and courses on a regional level to train non-nephrologist physicians and nurses working in dialysis units. A number of courses for fellows have also taken place since 2010 through the ISN GO Fellowship Program.
The Istanbul branch has published five books on the content of its monthly Sunday Training Courses that have been organized over the last six years. Every year, the society also publishes booklets on the Registry of Nephrology, Dialysis and Transplantation in Turkey. English versions of reports from 1998 to 2009 can be found HERE.
Since 1995, TSN has focused on collecting individual patient data. In 2009, out of 795 centers, 60,000 patients were on renal replacement therapy and 53,500 were on dialysis (with 48,000 of these on hemodialysis and 5,500 on peritoneal dialysis). As part of the Turkish National Registry activities, a field survey on “Chronic Renal Disease Prevalence in Turkey” was also carried out, encompassing 15,000 subjects from all over the country. This survey was finished in 2010 and an article evaluating its results accepted for publication in Nephrology Dialysis Transplantation.
The Turkish Nephrology Dialysis and Transplantation Journal is the society's official journal, published three times a year. The 20th volume has just been published. Articles are in Turkish or in English but all have abstracts both in Turkish and English. TSN National Congress Abstracts are also published in the journal's supplement issues. The journal also publishes supplements devoted to special topics covered in various educational meetings and courses organized by TSN.
For more information about TSN, CLICK HERE.
ISN admitted into official relations with World Health Organization Featured
Written by Sally Horspool
Brussels, Belgium (February 21, 2012) – January 2012 marks the International Society of Nephrology’s (ISN) acceptance into official relations with the World Health Organization (WHO). The WHO’s Executive Board admitted ISN during its 130th session. ISN is one of only 182 non- governmental organizations worldwide to currently be in official relations with the WHO, as well as the first and only kidney-related organization to have attained this prestigious status.
ISN President, John Feehally welcomed the announcement, "I am excited that ISN now has official relations with WHO. I am sure this will give ISN new opportunities to make clear the importance of kidney disease to global health, and show how cost-effective changes in healthcare systems can make a real difference to the problems caused by kidney disease worldwide."
Giuseppe Remuzzi, ISN President Elect, is leading ISN’s efforts with the WHO and looking at how this new relationship can assist ISN’s programs. “It is a unique opportunity to raise awareness about kidney disease worldwide especially in emerging countries. The ISN-WHO official relationship will hopefully implement detection and prevention programs, reduce the costs of chronic kidney disease and prevent cardiovascular complications of obesity and diabetes and ultimately improve public health”.
For further information, please contact:
John Feehally, ISN President Tel: +44 116 258 4132
Luca Segantini, ISN Executive Director Tel: +32 2 808 0420
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
CLICK HERE to read the full press release.
ISN and the International Pediatric Nephrology Association (IPNA) have recently signed an agreement to develop a partnership and to express their mutual commitment to the advancement of nephrology. IPNA is a professional organization of pediatric nephrologists with about 1600 members from more than 100 countries. Its goal is to promote knowledge and communication among those interested in pediatric kidney disease, improving the care and treatment of children with kidney and urinary tract abnormalities. To accomplish its goal, IPNA has developed specific programs of education and training. Click here to find out more.
In its philanthropic and humanitarian mission, ISN supports nephrology education and training worldwide though its Global Outreach Programs and in particular the ISN Fellowship Program. The first expression of the ISN/IPNA partnership will be the establishment of a joint ISN-IPNA Fellowship.
ISN will support this Fellowship from within its existing Fellowship Program budget, provided that 50% of each full year stipend is matched by 50% from IPNA. An initial commitment will be made by both parties for 3 years, between 2011-2013. By highlighting this partnership, both societies hope to motivate other institutions in the developed world to express their philanthropic commitment through partnerships with ISN and IPNA.
Printing a human kidney: Anthony Atala on TED.com
Written by Luca SegantiniFresh from TED2011 last week: Surgeon Anthony Atala demonstrates an early-stage experiment that could someday solve the organ-donor problem: a 3D printer that uses living cells to output a transplantable kidney. Using similar technology, Dr. Atala’s young patient Luke Massella received an engineered bladder 10 years ago; we meet him onstage. (Recorded at TED2011, March 2011, in Long Beach, California. Duration: 17:24)
ISN is happy to announce the start of a new partnership with UKidney.com, a leading resource in nephrology education. From today, ISN will become UKidney’s exclusive educational partner.
David Harris, Chair of the ISN Education Committee, is looking forward to the collaboration which he believes will expand access to educational materials and opportunities for nephrologists worldwide, with a special focus on developing countries.
“ISN, with the help of UKidney.com, will deliver the latest interactive education resources online to build a new ISN educational portal. This includes interactive histopathology images, videos on interventional procedures, clinical practice guidelines, meeting coverage and more. It promises to be very instructive and enjoyable to use,” he explains.
“We are also making many of UKidney’s interactive offerings available to ISN members and will feature content created by ISN on UKidney.com itself,” adds Jordan Weinstein, director of UKidney.com.
ISN and IPNA consensus statement to appear in KI Featured
Written by Sally HorspoolISN and the International Pediatric Nephrology Association (IPNA) have written and endorsed a consensus statement describing how young people with kidney disease should be cared for when they are transferred from pediatric to adult nephrology units. The statement is set to be published in the September edition of Kidney International and IPNA’s Pediatric Nephrology Journal.
It will provide a basis for developing appropriate recommendations for local clinical practice. The presence of a more diverse multi professional team to support children and their families is one of the major differences between pediatric and adult care. Wherever managed, young people from 14 to 24 years old also need special consideration and it is important that their viewpoints are considered when a transfer between units takes place.
Stay tuned for more information as it happens online.
BC Renal Agency and BC Transplant: organ trafficking and transplant tourism brochure Featured
Written by Sally HorspoolEvery year, a number of British Columbians are pursuing black market kidney transplants in countries such as India, China and the Philippines. In doing so, they may be risking their own lives, and those of the donors — many of whom are exploited.
With the goal of raising awareness and prompting discussion among care providers and patients about the dangers and ethics of organ trafficking and transplant tourism, the BC Renal Agency and BC Transplant have produced a new brochure called, “Thinking of Buying a Kidney? Stop! What You Need to Know.”
Available in English, Chinese, Tagalog (Filipino) and Punjabi, copies of the brochure were distributed to renal and transplant clinics across the province. Additional information and an online order form to request copies are available on the BC Renal Agency’s website.
Now available: 2011 DNT workshop and 2010 ANZSN meeting presentations Featured
Written by Sally HorspoolYou can now access the latest presentations from the 2011 Dialysis Nephrology Transplant Workshop and the 2010 Australian and New Zealand Society of Nephrology (ANZSN) meetings.
Download them now at the following link.
ANZSN sets out to promote and support the study of kidney and urinary tract health and disease. It ensures the highest professional standards for the practice of nephrology in Australia and New Zealand.
The Society provides information about research grants, scholarships and vacant nephrological positions. Every year, it awards a number of travel grants and research fellowships, grants and scholarships.
For more information, visit: http://nephrology.edu.au
ISN Amgen prize handed to Giuseppe Remuzzi Featured
Written by Jesper Lillelund
At this year’s World Congress of Nephrology, several prizes were given to ISN members including the ISN Amgen award. Giuseppe Remuzzi was the proud recipient of the award this year.
The ISN Amgen International Prize for Therapeutic Advancement in Nephrology was established in 2003 to honor scientists who have increased the understanding and improved the treatment of kidney disease through basic or clinical scientific research leading to therapeutic advances.
As Director of the Division of Nephrology and Dialysis at the Ospedali Riuniti di Bergamo, Remuzzi is the head and founder of the Negri Bergamo Laboratories at the Mario Negri Institute for Pharmalogical Research, Italy.
He also chairs the ISN Global Outreach (GO) Research and Prevention (R&P) Program and his vision has led to a variety of research results from his laboratory contributing to the advancement of nephrology over the last two decades. “As soon as diabetes is diagnosed, kidneys should be protected before they are affected by the disease. Data from our BENEDICT study has shown that this is feasible,” he says.
For more information about the ISN GO R&P Program, click here.
For details on Amgen activities, visit: http://www.amgen.com/